Drug Approval | March 11, 2023
USFDA completes inspection of Lupin’s Vizag facility
The inspection concluded with no observations
The inspection concluded with no observations
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
Time to combine innovation, access and technology to deliver positive patient outcomes
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
Plantasens Pro LM is 100% natural, readily biodegradable, COSMOS and Natrue certified
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
Ashland’s pharmaceutical business is well known for acetylenics, cellulosics, and film coatings
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
Digital success is contingent on the way a company organizes itself around technology
Subscribe To Our Newsletter & Stay Updated
